■ A systematic review of guidelines for managing rheumatoid arthritis
Mian A, Ibrahim F, Scott DL.
BMC Rheumatol. 2019, vol 22;3:42
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805606/
■ Pharmacological management of osteroporosis in rheumatoid arthritis patients: a review of the literature and practical guide
Hennie G. Raterman, Willem F. Lems
Drug Aging 2019; 36(12): 1061–1072
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884430/
■ Methorexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment
Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R.
Front Med (Lausanne). 2019 Oct 23;6:238
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819370/
■ Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology
C T K Ho, C C Mok, T T Cheung et al
Clinical Rheumatology 2019, vol 38: 3331-3350
https://link.springer.com/article/10.1007/s10067-019-04761-5
■ 2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis
Mota, Licia Maria Henrique da et al.
Adv. rheumatol., 2018, vol.58. ISSN 2523-3106
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2523-31062018000100300&lng=pt&nrm=iso
■ EULAR recommendation for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updart
J S Smolen, R Landewe, J Bijlsma et al
Adv. rheumatol., 2018, vol.58. ISSN 2523-3106
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2523-31062018000100300&lng=pt&nrm=iso
Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Data: jan 2020